DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+5.25%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(+6.9%)
Cap. Flow
+$5.48M
Cap. Flow
% of AUM
3.78%
Top 10 Holdings %
Top 10 Hldgs %
49.02%
Holding
80
New
17
Increased
21
Reduced
14
Closed
4
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$2.68M |
| 2 |
Turning Point Brands
TPB
|
$2M |
| 3 |
Amgen
AMGN
|
$1.53M |
| 4 |
Johnson & Johnson
JNJ
|
$1.01M |
| 5 |
Lifecore Biomedical
LFCR
|
$846K |
Top Sells
| 1 |
AbbVie
ABBV
|
$3.29M |
| 2 |
Biogen
BIIB
|
$1.36M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.13M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$725K |
| 5 |
Newmont
NEM
|
$368K |
Sector Composition
| 1 | Healthcare | 45.84% |
| 2 | Technology | 18.88% |
| 3 | Communication Services | 8.18% |
| 4 | Consumer Discretionary | 4.1% |
| 5 | Energy | 3.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Micron Technology
MU
$133B
| $10.1M | 5.32% | 159,500 +2,000 | +1% | +$126K |
|
2
argenx
ARGX
$43.6B
| $10M | 5.29% | 25,700 | – | – |
|
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $8.67M | 4.58% | 71,650 -9,350 | -12% | -$1.13M |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $8.03M | 4.24% | 11,175 +150 | +1% | +$108K |
|
|
ITCI
5
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.79M | 3.58% | 107,157 -11,443 | -10% | -$725K |
|
|
6
AbbVie
ABBV
$372B
| $6.41M | 3.38% | 47,550 -24,450 | -34% | -$3.29M |
|
7
Prothena Corp
PRTA
$441M
| $5.79M | 3.06% | 84,750 +500 | +0.6% | +$34.1K |
|
8
Xencor
XNCR
$580M
| $5.37M | 2.84% | 215,000 +5,000 | +2% | +$125K |
|
9
Oracle
ORCL
$635B
| $5.12M | 2.71% | 43,000 | – | – |
|
10
Energy Transfer Partners
ET
$60.8B
| $4.79M | 2.53% | 377,000 +3,000 | +0.8% | +$38.1K |
|
11
Bank of America
BAC
$376B
| $3.94M | 2.08% | 137,250 -750 | -0.5% | -$21.5K |
|
12
SPDR Gold Trust
GLD
$107B
| $3.83M | 2.02% | 21,500 | – | – |
|
|
13
Amgen
AMGN
$155B
| $3.75M | 1.98% | 16,875 +6,875 | +69% | +$1.53M |
|
14
iShares Gold Trust
IAU
$50.6B
| $3.64M | 1.92% | 100,000 | – | – |
|
15
Eli Lilly
LLY
$657B
| $3.52M | 1.86% | 7,500 -750 | -9% | -$352K |
|
16
Advanced Micro Devices
AMD
$264B
| $3.47M | 1.84% | 30,500 +500 | +2% | +$57K |
|
17
Apple
AAPL
$3.45T
| $2.86M | 1.51% | 14,750 | – | – |
|
|
18
Zimmer Biomet
ZBH
$21B
| $2.68M | 1.42% | +18,397 | New | +$2.68M |
|
19
Incyte
INCY
$16.5B
| $2.52M | 1.33% | 40,500 -2,000 | -5% | -$125K |
|
|
SGEN
20
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.24M | 1.18% | 11,650 -500 | -4% | -$96.2K |
|
|
AOD
21
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.09M | 1.11% | 253,500 | – | – |
|
22
AT&T
T
$209B
| $2.03M | 1.07% | 127,500 | – | – |
|
|
23
Turning Point Brands
TPB
$1.79B
| $2M | 1.06% | +83,500 | New | +$2M |
|
24
Nuveen Credit Strategies Income Fund
JQC
$754M
| $1.97M | 1.04% | 390,000 +26,000 | +7% | +$131K |
|
25
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $1.78M | 0.94% | 50,000 +5,000 | +11% | +$178K |
|